Member Info for JohnHenry

Agree, excellent informative presentation.

Not at All LBC, the demerger FU is just a blip in the SP. Once the SP bottoms and turns we should see a good rise into what will be a news rich period.

Agree LBC the demerger process was a total FU and we are still seeing confusion in the market even now.

The BOD are scientists not business men imho.I would like to see a more Market savvy CEO at TILS.

Letsbecool if you have done your research and invested for the med - long term then todays price shouldnt be a concern unless the story has changed, And of course investing money that you can afford to loose as that should be your first consideration when invested in the stockmarket.
Unfortunately Most peeps dont consider this.

added more at 82p looking like we a close to the bottom.

BM3 its a case of no visible news until the end of 2020. Weak holders/ Traders moving on in a very low volume market.

Lots of ramping up of testing, however GDR are not really involved in the UK, maybe a contract in Europe. India appears dead, FDA approvals needed in the US. which basically leaves SA.

The U.S. Food and Drug Administration (FDA) has approved emergency use for the first Covid-19 test that can be conducted entirely at home.
The nasal swab test, which is eligible for use by patients aged 14 and over suspected of having the disease, can provide results within 30 minutes.
The test created by California-based Lucira Health received emergency use authorization late Tuesday.

His level of basic knowledge is very poor. POC tests are accurate if the patient are exposed to a large viral load if not tests can lead to false negatives.

£5 k seller still getting out.

Basically you cant buy on one exchange and convert to another when the shares are dual listed.

Twitter is full of BS

Jab thats because GW delisted from AIM, TILS are not.

Have you ever consider the faint possibility that the US may fall to meet the UK price.

As i said yesterday there is literally no volume on the Nas.

Chairmans statement We have ongoing dialogue with the Indian regulators but progress has been slow. In November the FDA provided initial feedback of our EUA application, and requested additional information primarily related to new requirements and methodologies they introduced after our initial submission earlier in the year. We also provided additional data to the World Health Authority (WHO) in November. At this time we do not have visibility from the FDA, WHO or the Indian regulatory agency on approval timelines

is certainly a concern and needs a full and honest answer from Budd.

But your couldnt buy SFA, managed 15k

TBH technick im surprised they were able to claim the vaccine results in such a non scientific controlled study. Now if the results had come from a Challenge Study then fair play. Study was so vague.

i dont think a £38M MKT CAP is justifiable on that news.

Overall i think the Markets will drop the price.

Excellent news.